NASDAQ:MSON - Misonix Stock Price, Forecast & News

Misonix's stock was trading at $10.68 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, MSON stock has decreased by 14.0% and is now trading at $9.18. View which stocks have been mosted impacted by Coronavirus.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Misonix.

Misonix is scheduled to release its next quarterly earnings announcement on Wednesday, May 13th 2020. View our earnings forecast for Misonix.

Misonix, Inc. (NASDAQ:MSON) released its quarterly earnings data on Wednesday, February, 5th. The medical equipment provider reported ($0.33) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by $0.08. The medical equipment provider had revenue of $19.72 million for the quarter. Misonix had a negative return on equity of 7.80% and a negative net margin of 14.40%. View Misonix's earnings history.

Misonix updated its FY 2020 After-Hours earnings guidance on Wednesday, February, 5th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $46.618 million, compared to the consensus revenue estimate of $73.25 million.

2 Wall Street analysts have issued 12 month target prices for Misonix's stock. Their forecasts range from $27.00 to $30.00. On average, they anticipate Misonix's stock price to reach $28.50 in the next year. This suggests a possible upside of 210.5% from the stock's current price. View analysts' price targets for Misonix.

Media coverage about MSON stock has trended very negative this week, according to InfoTrie Sentiment. The research firm ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Misonix earned a coverage optimism score of -3.3 on InfoTrie's scale. They also gave news headlines about the medical equipment provider a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View the latest news aboutMisonix.

Some companies that are related to Misonix include Oxford Instruments (OXINF), Emis Group (EMIS), Partner Communications (PTNR), Simulations Plus (SLP), Maxar Technologies (MAXR), Inseego (INSG), Eventbrite (EB), Opera (OPRA), Axcelis Technologies (ACLS), First Derivatives (FDP), Hansen Technologies (HSN), Smart Global (SGH), Universal Electronics (UEIC), Changyou.Com (CYOU) and Quotient Technology (QUOT).

Based on aggregate information from My MarketBeat watchlists, some companies that other Misonix investors own include Edap Tms (EDAP), Canopy Growth (CGC), Varian Medical Systems (VAR), Second Sight Medical Products (EYES), Sociedad Quimica y Minera de Chile (SQM), NovaBay Pharmaceuticals (NBY), Aurora Cannabis (ACBFF), Allena Pharmaceuticals (ALNA), Fate Therapeutics (FATE) and Amicus Therapeutics (FOLD).

Misonix trades on the NASDAQ under the ticker symbol "MSON."

Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of MSON stock can currently be purchased for approximately $9.18.

Misonix has a market capitalization of $159.36 million and generates $38.85 million in revenue each year. Misonix employs 118 workers across the globe. View additional information about Misonix.

The official website for Misonix is http://www.misonix.com/.

Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555.